Roslan Harun

953 total citations
36 papers, 678 citations indexed

About

Roslan Harun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roslan Harun has authored 36 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Roslan Harun's work include RNA modifications and cancer (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Cancer-related gene regulation (4 papers). Roslan Harun is often cited by papers focused on RNA modifications and cancer (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Cancer-related gene regulation (4 papers). Roslan Harun collaborates with scholars based in Malaysia, Yemen and Bangladesh. Roslan Harun's co-authors include Norfilza Mohd Mokhtar, Rahman Jamal, Wan Zurinah Wan Ngah, Isa Mohamed Rose, Ismail Sagap, Rahman Jamal, Azman Ali Raymond, Nor Azian Abdul Murad, Azmi Mohd Tamil and Suzana Makpol and has published in prestigious journals such as PLoS ONE, Molecules and Frontiers in Pharmacology.

In The Last Decade

Roslan Harun

36 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roslan Harun Malaysia 16 232 163 141 132 90 36 678
Evgeny Krynetskiy United States 16 245 1.1× 83 0.5× 55 0.4× 69 0.5× 37 0.4× 36 729
Susan Loftus United States 6 89 0.4× 147 0.9× 60 0.4× 89 0.7× 44 0.5× 10 579
Ido Laish Israel 12 116 0.5× 120 0.7× 77 0.5× 51 0.4× 62 0.7× 46 797
Masayuki Ohbayashi Japan 14 224 1.0× 297 1.8× 83 0.6× 49 0.4× 108 1.2× 34 664
Jeong Seok Hwa South Korea 13 343 1.5× 86 0.5× 103 0.7× 140 1.1× 26 0.3× 45 769
Megan Kane United States 11 259 1.1× 85 0.5× 41 0.3× 38 0.3× 69 0.8× 28 660
Kalyane Bach‐Ngohou France 18 209 0.9× 165 1.0× 62 0.4× 125 0.9× 75 0.8× 49 946
Anja Rudolph Germany 17 360 1.6× 305 1.9× 99 0.7× 262 2.0× 119 1.3× 28 1000
Charlotte Brasch‐Andersen Denmark 19 497 2.1× 302 1.9× 54 0.4× 80 0.6× 124 1.4× 49 1.1k
B Kattman United States 9 207 0.9× 82 0.5× 31 0.2× 65 0.5× 77 0.9× 25 676

Countries citing papers authored by Roslan Harun

Since Specialization
Citations

This map shows the geographic impact of Roslan Harun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roslan Harun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roslan Harun more than expected).

Fields of papers citing papers by Roslan Harun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roslan Harun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roslan Harun. The network helps show where Roslan Harun may publish in the future.

Co-authorship network of co-authors of Roslan Harun

This figure shows the co-authorship network connecting the top 25 collaborators of Roslan Harun. A scholar is included among the top collaborators of Roslan Harun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roslan Harun. Roslan Harun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngah, Wan Zurinah Wan, et al.. (2022). Inhibitory Mechanism of Combined Hydroxychavicol With Epigallocatechin-3-Gallate Against Glioma Cancer Cell Lines: A Transcriptomic Analysis. Frontiers in Pharmacology. 13. 844199–844199. 6 indexed citations
2.
Hanif, Ezanee Azlina Mohamad, et al.. (2021). Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells. Molecular Biology Reports. 48(2). 1493–1503. 5 indexed citations
3.
Hanif, Ezanee Azlina Mohamad, et al.. (2019). Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 20(2). 509–517. 9 indexed citations
5.
Murad, Nor Azian Abdul, et al.. (2017). NFIX as a Master Regulator for Lung Cancer Progression. Frontiers in Pharmacology. 8. 540–540. 24 indexed citations
6.
Murad, Nor Azian Abdul, Sue‐Mian Then, Jegan Thanabalan, et al.. (2017). Mitochondrial DNA Mutations in Grade II and III Glioma Cell Lines Are Associated with Significant Mitochondrial Dysfunction and Higher Oxidative Stress. Frontiers in Physiology. 8. 231–231. 19 indexed citations
7.
Mokhtar, Norfilza Mohd, Roslan Harun, Isa Mohamed Rose, et al.. (2016). A 19-Gene expression signature as a predictor of survival in colorectal cancer. BMC Medical Genomics. 9(1). 58–58. 72 indexed citations
8.
Mutalib, Nurul‐Syakima Ab, et al.. (2016). MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers. Asian Pacific Journal of Cancer Prevention. 17(1). 25–35. 22 indexed citations
9.
Murad, Nor Azian Abdul, et al.. (2016). Silencing of PROS1 induces apoptosis and inhibits migration and invasion of glioblastoma multiforme cells. International Journal of Oncology. 49(6). 2359–2366. 25 indexed citations
10.
Mokhtar, Norfilza Mohd, et al.. (2015). Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncology Reports. 34(1). 22–32. 40 indexed citations
11.
Jamal, Rahman, et al.. (2015). A Hybrid One-Way ANOVA Approach for the Robust and Efficient Estimation of Differential Gene Expression with Multiple Patterns. PLoS ONE. 10(9). e0138810–e0138810. 9 indexed citations
12.
Mokhtar, Norfilza Mohd, et al.. (2014). Exploring breast carcinogenesis through integrative genomics and epigenomics analyses. International Journal of Oncology. 45(5). 1959–1968. 5 indexed citations
13.
Jamal, Asif, et al.. (2014). Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells. BMC Complementary and Alternative Medicine. 14(1). 213–213. 15 indexed citations
14.
Ismail, Nor Azlin Mohamed, Zaleha Abdullah Mahdy, Rohana Jaafar, et al.. (2013). Single nucleotide polymorphism for certain genes involved in gestational diabetes with risk factors and complications positive. Sains Malaysiana. 42(11). 1613–1618. 2 indexed citations
15.
A, Bán, et al.. (2012). Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation. BMC Pulmonary Medicine. 12(1). 27–27. 28 indexed citations
16.
Saif-Ali, Riyadh, et al.. (2011). Association of Hepatocyte Nuclear Factor 4 Alpha Polymorphisms with Type 2 Diabetes With or Without Metabolic Syndrome in Malaysia. Biochemical Genetics. 50(3-4). 298–308. 4 indexed citations
17.
Teh, Lay Kek, et al.. (2011). The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1. The AAPS Journal. 14(1). 52–59. 53 indexed citations
18.
Haerian, Batoul Sadat, Kheng Seang Lim, Hui Jan Tan, et al.. (2011). Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Epileptic Disorders. 13(1). 65–75. 14 indexed citations
19.
Haerian, Batoul Sadat, Roslan Harun, Azman Ali Raymond, et al.. (2010). ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: A systematic review and meta-analysis. Seizure. 19(6). 339–346. 68 indexed citations
20.
Jamal, Rahman, et al.. (2005). Abnormalities in lung function among multiply-transfused thalassemia patients: results from a thalassemia center in Malaysia.. PubMed. 36(1). 265–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026